• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

6,623
2,052
2,047
1,709
1,518

COUNTRY

996
814
243
235
194

CATEGORIES

  • 858
  • 185
  • 123
  • 317
  • 458
  • 230
  • 254
  • 65
  • 76
  • 792
  • 1,399
  • 855
  • 24
  • 410
  • 1,278
  • 2,246
  • 25
  • 266
  • 49

PRICE

5,035
10,471
19,463
25,484

PUBLISHED

3,572
5,296
9,418
25,484

PRODUCT TYPE

21,434
1,950
957
877
164
37
21
21
16
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Rytary/IPX066 (Parkinson's Disease) - Forecast and Market analysis to 2022

Rytary/IPX066 (Parkinson’s Disease) - Forecast and Market analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor,...

March 2014
FROM

Tozadenant (Parkinson's Disease) - Forecast and Market Analysis to 2022

Tozadenant (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and...

March 2014
FROM

Nouriast (Parkinson's Disease) - Forecast and Market Analysis to 2022

Nouriast (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural...

March 2014
FROM

Duodopa (Parkinson's Disease) - Forecast and Market Analysis to 2022

Duodopa (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural...

March 2014
FROM

Sinemet (Parkinson's Disease) - Forecast and Market Analysis to 2022

Sinemet (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural...

March 2014
FROM

Requip/Requip XL (Parkinson's Disease) - Forecast and Market Analysis to 2022

Requip/Requip XL (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor,...

March 2014
FROM

Madopar (Parkinson's Disease) - Forecast and Market Analysis to 2022

Madopar (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural...

March 2014
FROM

Apokyn (Parkinson's Disease) - Forecast and Market Analysis to 2022

Apokyn (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural...

March 2014
FROM

Azilect (Parkinson's Disease) - Forecast and Market Analysis to 2022

Azilect (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural...

March 2014
FROM

Opicapone (Parkinson's Disease) - Forecast and Market Analysis to 2022

Opicapone (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and...

March 2014
FROM

Neupro (Parkinson's Disease) - Forecast and Market Analysis to 2022

Neupro (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural...

March 2014
FROM

Cervarix (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022

Cervarix (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available...

March 2014
FROM

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - US Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - US Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became...

March 2014
FROM

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Australia Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Australia Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV)...

March 2014
FROM

V503 (Prophylactic Human Papillomavirus Vaccines) - Forecast and Market Analysis to 2022

V503 (Prophylactic Human Papillomavirus Vaccines) - Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available...

March 2014
FROM

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - 5EU Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - 5EU Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became...

March 2014
FROM

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Japan Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Japan Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV)...

March 2014
FROM

Gardasil (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022

Gardasil (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available...

March 2014
FROM

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Canada Drug Forecast and Market Analysis to 2022

PharmaPoint: Prophylactic Human Papillomavirus Vaccines - Canada Drug Forecast and Market Analysis to 2022 Summary The first prophylactic vaccine for immunization against human papillomavirus (HPV)...

March 2014
FROM
Drug, Cosmetic & Toiletry Wholesaling in the US Drug, Cosmetic & Toiletry Wholesaling in the US - Product Thumbnail Image

Drug, Cosmetic & Toiletry Wholesaling in the US

Drug, Cosmetic & Toiletry Wholesaling in the US Wholesalers of drugs, cosmetics and toiletries emerged from the recession largely unscathed, bolstered by demand for pharmaceutical products. In addition,...

March 2014
FROM
Loading Indicator

Our Clients

Our clients' logos